Definium Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Definium Therapeutics, Inc. (DFTX) reported Increase (Decrease) in Accounts Payable of $1.62 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- Definium Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$162.00K, a 108.32% decline year-over-year.
- Definium Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.78M, a 589.92% increase year-over-year.
- Definium Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$2.77M.
- Definium Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $3.90M.
- Definium Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2025 was $3.34M.
- Definium Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$2.13M, a 204.99% decline from fiscal 2023.
- Definium Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2023 was $2.02M.
- Definium Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$2.06M, a 260.37% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 7 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.62M 10-Q · filed 2026-08-06 | -$1.15M derived: sum of 3 quarters · filed 2026-08-06 | $2.75M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $1.78M 10-Q · filed 2026-05-07 | -$986.00K derived: sum of 2 quarters · filed 2026-05-07 | $2.91M derived: sum of 3 quarters · filed 2026-05-07 | $4.86M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.13M derived: sum of 2 quarters · filed 2026-02-26 | $3.08M derived: sum of 3 quarters · filed 2026-08-06 | $3.34M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.84M derived: sum of 2 quarters · filed 2026-08-06 | $6.10M 10-Q · filed 2025-11-06 | $5.96M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.21M 10-Q · filed 2026-08-06 | $2.07M derived: sum of 3 quarters · filed 2026-08-06 | $1.53M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $258.00K 10-Q · filed 2026-05-07 | $119.00K derived: sum of 2 quarters · filed 2026-05-07 | -$415.00K derived: sum of 3 quarters · filed 2026-05-07 | -$3.38M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$673.00K derived: sum of 2 quarters · filed 2026-02-26 | -$3.63M derived: sum of 3 quarters · filed 2026-02-26 | -$2.13M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$534.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$3.50M derived: sum of 2 quarters · filed 2025-11-06 | -$1.99M 10-Q · filed 2025-11-06 | -$5.50M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | -$2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$1.45M 10-Q · filed 2025-07-31 | -$4.96M derived: sum of 3 quarters · filed 2025-07-31 | -$5.89M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-03-31 | $1.51M 10-Q · filed 2025-05-08 | -$2.00M derived: sum of 2 quarters · filed 2025-05-08 | -$2.93M derived: sum of 3 quarters · filed 2025-05-08 | $3.33M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$3.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$4.44M derived: sum of 2 quarters · filed 2025-03-06 | $1.82M derived: sum of 3 quarters · filed 2025-03-06 | $2.02M 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$931.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $5.33M derived: sum of 2 quarters · filed 2024-11-07 | $5.54M 10-Q · filed 2024-11-07 | $6.81M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $6.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $6.47M 10-Q · filed 2024-08-13 | $7.74M derived: sum of 3 quarters · filed 2024-08-13 | $7.84M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $209.00K 10-Q · filed 2024-05-08 | $1.48M derived: sum of 2 quarters · filed 2024-05-08 | $1.58M derived: sum of 3 quarters · filed 2024-05-08 | -$1.00M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.37M derived: sum of 2 quarters · filed 2024-02-28 | -$1.21M derived: sum of 3 quarters · filed 2024-02-28 | -$2.06M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$2.49M derived: sum of 2 quarters · filed 2023-11-02 | -$3.33M 10-Q · filed 2023-11-02 | -$2.68M derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | -$2.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$3.43M 10-Q · filed 2023-08-03 | -$2.78M derived: sum of 3 quarters · filed 2023-08-03 | -$2.10M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$843.00K 10-Q · filed 2023-05-04 | -$195.00K derived: sum of 2 quarters · filed 2023-05-04 | $490.00K derived: sum of 3 quarters · filed 2023-05-04 | -$1.14M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $648.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.33M derived: sum of 2 quarters · filed 2023-03-09 | -$299.00K derived: sum of 3 quarters · filed 2023-03-09 | $1.28M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $685.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$947.00K derived: sum of 2 quarters · filed 2022-11-10 | $634.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$51.00K 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $1.58M 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | $544.00K 10-K · filed 2022-03-28 | ||||
| 2019-12-31 | $1.22M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |